Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
admin A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday,…
Read MoreModerna
Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read MoreModerna stock slides 14% premarket after profit and revenue fall short of estimates and biotech offers soft guidance
Moderna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MoreModerna expects the shortage of its updated COVID-19 booster to soon be resolved
Moderna Inc. MRNA, -0.40% said Wednesday that it expects to resolve supply issues for its…
Read MoreModerna expects the shortage of its updated COVID-19 booster to soon be resolved
Moderna Inc. MRNA, -0.74% said Wednesday that it expects to resolve supply issues for its…
Read MoreVaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said…
Read More